Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.

Literature DB >> 6334491

Comparison of the activities of penicillin G and new beta-lactam antibiotics against clinical isolates of Bacteroides species.

K E Aldridge, C V Sanders, A Janney, S Faro, R L Marier.

Abstract

MICs were determined for 218 clinical isolates of Bacteroides by a broth microdilution method. Imipenem was the most active antibiotic tested. Azlocillin, mezlocillin, and cefoxitin had comparable activities, with resistance among members of the B. fragilis group and B. capillosus. Ceftizoxime was the most active cephalosporin tested. Members of the B. fragilis group showed high levels of resistance to cefotetan and ceftazidime. Resistance to penicillin G varied from 0 to 14%.

Entities: Chemical Species

Mesh：

Substances：

Year: 1984 PMID： 6334491 PMCID： PMC176181 DOI： 10.1128/AAC.26.3.410

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

23 in total

1. The bacteriology of acute pelvic inflammatory disease.

Authors: A W Chow; K L Malkasian; J R Marshall; L B Guze
Journal: Am J Obstet Gynecol Date: 1975-08-01 Impact factor: 8.661

2. Bacteroides bivius and Bacteroides disiens in obstetrical patients: clinical findings and antimicrobial susceptibilities.

Authors: D R Snydman; F P Tally; R Knuppel; J Landrigan; S L Gorbach; J G Bartlett
Journal: J Antimicrob Chemother Date: 1980-07 Impact factor: 5.790

3. High-dose cefamandole therapy in obstetric and gynecologic infections.

Authors: S A Gall; G B Hill
Journal: Am J Obstet Gynecol Date: 1980-08-15 Impact factor: 8.661

4. Beta-lactamase activity in anaerobic bacteria.

Authors: A E Weinrich; V E Del bene
Journal: Antimicrob Agents Chemother Date: 1976-07 Impact factor: 5.191

5. Susceptibility of anaerobic bacteria in vitro to 23 antimicrobial agents.

Authors: V T Bach; H Thadepalli
Journal: Chemotherapy Date: 1980 Impact factor: 2.544

Review 6. Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.

Authors: B D Kirby; W L George; V L Sutter; D M Citron; S M Finegold
Journal: Rev Infect Dis Date: 1980 Nov-Dec

7. Susceptibility of anaerobic bacteria to ten antimicrobial agents.

Authors: P C Appelbaum; S A Chatterton
Journal: Antimicrob Agents Chemother Date: 1978-09 Impact factor: 5.191

8. Bacteriostatic and bactericidal activities of various antibiotics against Bacteroides fragilis.

Authors: R J Zabransky; J A Johnston; K J Hauser
Journal: Antimicrob Agents Chemother Date: 1973-02 Impact factor: 5.191

9. Microbiology and pathogenesis of acute salpingitis as determined by laparoscopy: what is the appropriate site to sample?

Authors: R L Sweet; D L Draper; J Schachter; J James; W K Hadley; G F Brooks
Journal: Am J Obstet Gynecol Date: 1980-12-01 Impact factor: 8.661

10. Cefoxitin resistance to beta-lactamase: a major factor for susceptibility of bacteroides fragilis to the antibiotic.

Authors: G Darland; J Birnbaum
Journal: Antimicrob Agents Chemother Date: 1977-04 Impact factor: 5.191

19 in total

1. National Committee for Clinical Laboratory Standards agar dilution susceptibility testing of anaerobic gram-negative bacteria.

Authors: W J Brown
Journal: Antimicrob Agents Chemother Date: 1988-03 Impact factor: 5.191

Review 2. Susceptibility testing of anaerobic bacteria: myth, magic, or method?

Authors: H M Wexler
Journal: Clin Microbiol Rev Date: 1991-10 Impact factor: 26.132

Review 3. Current antimicrobial therapy of anaerobic infections.

Authors: C V Sanders; K E Aldridge
Journal: Eur J Clin Microbiol Infect Dis Date: 1992-11 Impact factor: 3.267

Review 4. Ceftizoxime: a third-generation cephalosporin active against anaerobic bacteria. Committee on Antimicrobial Agents, Canadian Infectious Disease Society.

Authors:
Journal: CMAJ Date: 1990-06-01 Impact factor: 8.262

5. Comparison of in vitro antibiograms of Bacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology.

Authors: K E Aldridge; H M Wexler; C V Sanders; S M Finegold
Journal: Antimicrob Agents Chemother Date: 1990-01 Impact factor: 5.191

6. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.

Authors: M V Borobio; A Pascual; M C Dominguez; E J Perea
Journal: Antimicrob Agents Chemother Date: 1986-10 Impact factor: 5.191

7. Effect of beta-lactamase inhibitors on the activities of various beta-lactam agents against anaerobic bacteria.

Authors: H M Wexler; E Molitoris; S M Finegold
Journal: Antimicrob Agents Chemother Date: 1991-06 Impact factor: 5.191

Review 8. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors: S P Clissold; P A Todd; D M Campoli-Richards
Journal: Drugs Date: 1987-03 Impact factor: 9.546

9. Use of cephalosporins for prophylaxis and therapy of polymicrobial infection in mice.

Authors: I Brook
Journal: Antimicrob Agents Chemother Date: 1993-07 Impact factor: 5.191

10. Efficacy of sulbactam in an in vitro model of mixed aerobic/anaerobic infections.

Authors: W R Heizmann; F Heilmann; B Egeler; H Werner
Journal: Infection Date: 1990 Mar-Apr Impact factor: 3.553